Evidence map›Paper›PMID 21226618›Full record

ReviewJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research2011

Sources and signals regulating type I interferon production: lessons learned from cytomegalovirus.

Shilpi Verma, Chris A Benedict

Open access · greenAbstract readReview
In one paragraph

Review in Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Single-Cell Transcriptome Analysis of CD34Frontiers in microbiology · 2019
    Article
  6. Cytomegalovirus: Shape-Shifting the Immune System.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Review
  7. Article
  8. Cardif (MAVS) Regulates the Maturation of NK Cells.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Article
  9. Article
  10. Review
  11. Article
  12. Viral modulation of programmed necrosis.Current opinion in virology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shilpi VermaDivision of Immune Regulation, La Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.
Chris A Benedict
La Jolla Institute for Immunology · US

Funding

Activation of NKT cells by cytomegalovirusR21AI076864 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI BENEDICT, CHRISTOPHER A, KRONENBERG, MITCHELL · 2009 to 2010
$519k
CMV UL144 targets the HVEM-BTLA cosignaling systemR56AI069298 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI BENEDICT, CHRISTOPHER A · 2009 to 2009
$425k
NIAID NIH HHS AI069298NIAID NIH HHS AI076864
6 · The paper itself

Abstract

Type I interferons (IFN-αβ) are pleiotropic cytokines critical for antiviral host defense, and the timing and magnitude of their production involve a complex interplay between host and pathogen factors. Mouse cytomegalovirus (a β-herpesvirus) is a persistent virus that induces a biphasic IFN-αβ response during the first days of infection. The cell types and molecular mechanisms governing these 2 phases are unique, with splenic stromal cells being a major source of initial IFN-αβ, requiring communication with B cells expressing lymphotoxin, a tumor necrosis factor family cytokine. Here we review the factors that regulate this lymphotoxin-IFN-αβ "axis" during cytomegalovirus infection, highlight how stroma-derived IFN-αβ contributes in other models, and discuss how deregulation of this axis can lead to pathology in some settings.

Indexed as

Signal TransductionAnimalsB-LymphocytesCytomegalovirusHerpesviridae InfectionsHumansImmunity, InnateInterferon Type ILymphotoxin alpha1, beta2 HeterotrimerLymphotoxin beta ReceptorStromal CellsInterferon Type ILymphotoxin alpha1, beta2 HeterotrimerLymphotoxin beta Receptor

Identifiers

PMID21226618
PMCPMC3036178
OpenAlexW2069934113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.